Swiss National Bank’s BioCryst Pharmaceuticals BCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.4M | Sell |
379,268
-2,000
| -0.5% | -$17.9K | ﹤0.01% | 1493 |
|
|
2025
Q1 | $2.86M | Sell |
381,268
-5,300
| -1% | -$39.8K | ﹤0.01% | 1566 |
|
|
2024
Q4 | $2.91M | Buy |
386,568
+22,600
| +6% | +$170K | ﹤0.01% | 1641 |
|
|
2024
Q3 | $2.77M | Hold |
363,968
| – | – | ﹤0.01% | 1670 |
|
|
2024
Q2 | $2.25M | Hold |
363,968
| – | – | ﹤0.01% | 1746 |
|
|
2024
Q1 | $1.85M | Sell |
363,968
-9,500
| -3% | -$48.3K | ﹤0.01% | 1879 |
|
|
2023
Q4 | $2.24M | Sell |
373,468
-41,900
| -10% | -$251K | ﹤0.01% | 1770 |
|
|
2023
Q3 | $2.94M | Buy |
415,368
+5,000
| +1% | +$35.4K | ﹤0.01% | 1603 |
|
|
2023
Q2 | $2.89M | Buy |
410,368
+8,000
| +2% | +$56.3K | ﹤0.01% | 1653 |
|
|
2023
Q1 | $3.36M | Sell |
402,368
-46,600
| -10% | -$389K | ﹤0.01% | 1515 |
|
|
2022
Q4 | $5.15M | Buy |
448,968
+8,800
| +2% | +$101K | ﹤0.01% | 1297 |
|
|
2022
Q3 | $5.55M | Buy |
440,168
+5,200
| +1% | +$65.5K | ﹤0.01% | 1216 |
|
|
2022
Q2 | $4.6M | Buy |
434,968
+9,500
| +2% | +$101K | ﹤0.01% | 1361 |
|
|
2022
Q1 | $6.92M | Buy |
425,468
+32,900
| +8% | +$535K | ﹤0.01% | 1235 |
|
|
2021
Q4 | $5.44M | Hold |
392,568
| – | – | ﹤0.01% | 1415 |
|
|
2021
Q3 | $5.64M | Buy |
392,568
+2,700
| +0.7% | +$38.8K | ﹤0.01% | 1376 |
|
|
2021
Q2 | $6.16M | Sell |
389,868
-13,600
| -3% | -$215K | ﹤0.01% | 1345 |
|
|
2021
Q1 | $4.1M | Buy |
403,468
+4,300
| +1% | +$43.7K | ﹤0.01% | 1577 |
|
|
2020
Q4 | $2.97M | Buy |
399,168
+6,900
| +2% | +$51.4K | ﹤0.01% | 1682 |
|
|
2020
Q3 | $1.35M | Buy |
392,268
+6,600
| +2% | +$22.7K | ﹤0.01% | 1919 |
|
|
2020
Q2 | $1.84M | Buy |
385,668
+86,868
| +29% | +$414K | ﹤0.01% | 1763 |
|
|
2020
Q1 | $598K | Buy |
298,800
+14,800
| +5% | +$29.6K | ﹤0.01% | 2101 |
|
|
2019
Q4 | $980K | Buy |
284,000
+144,100
| +103% | +$497K | ﹤0.01% | 2148 |
|
|
2019
Q3 | $401K | Hold |
139,900
| – | – | ﹤0.01% | 2412 |
|
|
2019
Q2 | $530K | Hold |
139,900
| – | – | ﹤0.01% | 2401 |
|
|
2019
Q1 | $1.14M | Buy |
139,900
+4,500
| +3% | +$36.6K | ﹤0.01% | 1996 |
|
|
2018
Q4 | $1.09M | Buy |
135,400
+15,400
| +13% | +$124K | ﹤0.01% | 1953 |
|
|
2018
Q3 | $916K | Hold |
120,000
| – | – | ﹤0.01% | 2191 |
|
|
2018
Q2 | $688K | Sell |
120,000
-51,300
| -30% | -$294K | ﹤0.01% | 2349 |
|
|
2018
Q1 | $817K | Hold |
171,300
| – | – | ﹤0.01% | 2186 |
|
|
2017
Q4 | $841K | Hold |
171,300
| – | – | ﹤0.01% | 2184 |
|
|
2017
Q3 | $898K | Buy |
171,300
+57,000
| +50% | +$299K | ﹤0.01% | 2123 |
|
|
2017
Q2 | $636K | Hold |
114,300
| – | – | ﹤0.01% | 2327 |
|
|
2017
Q1 | $960K | Buy |
114,300
+18,000
| +19% | +$151K | ﹤0.01% | 2062 |
|
|
2016
Q4 | $610K | Hold |
96,300
| – | – | ﹤0.01% | 2303 |
|
|
2016
Q3 | $425K | Hold |
96,300
| – | – | ﹤0.01% | 2401 |
|
|
2016
Q2 | $273K | Hold |
96,300
| – | – | ﹤0.01% | 2527 |
|
|
2016
Q1 | $263K | Buy |
96,300
+17,900
| +23% | +$48.9K | ﹤0.01% | 2521 |
|
|
2015
Q4 | $809K | Hold |
78,400
| – | – | ﹤0.01% | 1964 |
|
|
2015
Q3 | $894K | Buy |
78,400
+10,200
| +15% | +$116K | ﹤0.01% | 1837 |
|
|
2015
Q2 | $1.02M | Buy |
68,200
+1,900
| +3% | +$28.4K | ﹤0.01% | 1785 |
|
|
2015
Q1 | $599K | Hold |
66,300
| – | – | ﹤0.01% | 2074 |
|
|
2014
Q4 | $806K | Buy |
66,300
+2,400
| +4% | +$29.2K | ﹤0.01% | 1854 |
|
|
2014
Q3 | $625K | Sell |
63,900
-10,900
| -15% | -$107K | ﹤0.01% | 1951 |
|
|
2014
Q2 | $954K | Buy |
74,800
+19,600
| +36% | +$250K | ﹤0.01% | 1746 |
|
|
2014
Q1 | $584K | Buy |
55,200
+11,400
| +26% | +$121K | ﹤0.01% | 2046 |
|
|
2013
Q4 | $333K | Buy |
+43,800
| New | +$333K | ﹤0.01% | 2217 |
|